The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Singulair Paediatric 4 mg granules

Organon Pharma (Ireland) LimitedPA23198/014/002

Main Information

Trade NameSingulair Paediatric 4 mg granules
Active SubstancesMontelukast sodium
Dosage FormGranules
Licence HolderOrganon Pharma (Ireland) Limited
Licence NumberPA23198/014/002

Group Information

ATC CodeR03DC Leukotriene receptor antagonists
R03DC03 montelukast


License statusAuthorised
Licence Issued07/03/2003
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListMontelukast 4mg Granules
Interchangeable List CodeIC0023-008-041
Interchangeable List DocumentPDF of Interchangeable List
« Back